Clinical trial aimed at new therapeutic approch against HAM patients by pentosan polysulphate
Not Applicable
- Conditions
- HTLV-I associated myelopathy (HAM)
- Registration Number
- JPRN-UMIN000004492
- Lead Sponsor
- Department of Molecular Microbilogy and Immunology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
patients who both prothrombin time and activated partial thromboplastin time are more than normal ranges at screening test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of neurological signs, Improvement of neurogenic bladder, Decrease of HTLV-I proviral load in peripheral blood, Check of side effects
- Secondary Outcome Measures
Name Time Method